GALVANI BIOELECTRONICS LIMITED
Get an alert when GALVANI BIOELECTRONICS LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£5.8m
+4,257.1% vs 2024
Net assets
£13m
-86.6% lowest in 3 filed years
Employees
20
-9.1% lowest in 3 filed years
Profit before tax
-£94m
-424.6% lowest in 3 filed years
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
3 officer resignations in last 12 months
Multiple officers have left the board recently — see the People section for who.
Net assets
3-year trend · vs Industrials median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | — | — | — | — | |
| Operating profit | -£20,475,000 | -£18,416,000 | -£94,182,000 | -411.4% | |
| Profit before tax | -£19,624,000 | -£17,855,000 | -£93,668,000 | -424.6% | |
| Net profit | -£17,178,000 | -£15,917,000 | -£84,045,000 | -428% | |
| Cash | — | £133,000 | £5,795,000 | +4,257.1% | |
| Total assets less current liabilities | £97,079,000 | £101,332,000 | £13,038,000 | -87.1% | |
| Net assets | £93,392,000 | £97,083,000 | £13,038,000 | -86.6% | |
| Equity | £93,392,000 | £97,083,000 | £13,038,000 | -86.6% | |
| Average employees | 23 | 22 | 20 | -9.1% | |
| Wages | £3,814,000 | £2,990,000 | £3,600,000 | +20.4% | |
| Directors' remuneration | — | £131,909 | £45,648 | -65.4% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Return on capital employed | -21.1% | -18.2% | -722.4% | |
| Gearing (liabilities / total assets) | 7.5% | 6.8% | 37.4% | |
| Current ratio | 1.55x | 2.44x | 2.51x |
Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- GALVANI BIOELECTRONICS LIMITED 2016-04-29 → present
- GSK BIOELECTRONICS (NO.1) LIMITED 2016-02-03 → 2016-04-29
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- Deloitte LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The accompanying financial statements have been prepared on a going concern basis, on the assumption that the Company will have sufficient cash flows to continue to support the existing implanted patients. Management has prepared cash flow forecasts that include the costs associated with the close out of the studies, termination of employees, and the resourcing of the long term patient support plan which has received regulatory approval. The cash flow forecast indicates that the Company will have sufficient funds to meet its obligations. As such, the Directors are of the opinion that the Company can continue as a going concern given it has adequate cash for at least 12 months from the date of signing these financial statements.”
Group structure
- GALVANI BIOELECTRONICS LIMITED · parent
- Galvani Bioelectronics Inc. 100%
Significant events
- “On 1 April 2026, subsequent to the reporting date, the Board of Directors approved a plan to terminate the ongoing clinical studies conducted in the US, the Netherlands and the UK.”
- “Following this decision, the Company will commence an orderly termination of the clinical studies, including the closure of facilities, laboratories and systems, the termination of supplier and contractor arrangements, and a phased reduction in workforce. The Company's future operations will focus on providing support to the existing implanted patients.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 17 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Secretary | 2016-11-16 | — | — |
| COURTLAND, Calvin | Director | 2025-09-29 | Jun 1971 | American |
| GABRIEL, Kaigham Jacob, Dr | Director | 2016-11-16 | May 1955 | American |
| WILLIAMS, Subesh Ronald | Director | 2016-11-16 | May 1962 | British |
Show 17 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| ALTSHUL, Amy | Director | 2021-03-24 | 2025-01-30 |
| BRIN, Sergey | Director | 2016-11-16 | 2018-09-26 |
| CONRAD, Andrew Jason, Dr | Director | 2016-11-16 | 2021-04-21 |
| CORSICO, Christopher, Dr | Director | 2019-02-27 | 2025-03-28 |
| GILLETT, Stephen | Director | 2021-04-21 | 2022-12-01 |
| HIRSCH, Bradford, Dr | Director | 2022-01-19 | 2024-01-25 |
| MARKS, William, Dr | Director | 2022-12-01 | 2023-06-16 |
| MEHTA, Anurag | Director | 2023-06-16 | 2025-09-29 |
| OTIS, Brian Partick, Dr | Director | 2016-11-16 | 2022-01-19 |
| PARRAMON, Jordi, Dr | Director | 2018-09-26 | 2023-06-16 |
| PODREBARAC, Theresa, Dr | Director | 2025-04-08 | 2026-03-23 |
| SLAOUI, Mohamed Monsif, Dr | Director | 2016-11-16 | 2021-03-24 |
| TAK, Paul-Peter, Dr | Director | 2016-11-16 | 2018-08-31 |
| TRISTER, Andrew, Dr | Director | 2023-09-27 | 2026-05-01 |
| WALKER, Adam | Director | 2016-02-03 | 2016-11-16 |
| EDINBURGH PHARAMACEUTICALS INDUSTRIES LIMITED | Corporate Director | 2016-02-03 | 2016-11-16 |
| GLAXO GROUP LIMITED | Corporate Director | 2016-02-03 | 2016-11-16 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Alphabet Inc. | Corporate entity | Shares 25–50%, Voting 25–50%, Appoints directors | 2016-11-16 | Active |
| Setfirst Limited | Corporate entity | Shares 50–75%, Voting 50–75%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 88 total filings
Material constitutional events — rename, articles re-file, resolution
- 2026-05-15 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-07-14 | AA | accounts | Accounts with accounts type full | |
| 2026-06-10 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2026-05-15 | RESOLUTIONS | resolution | Resolution | |
| 2026-05-07 | TM01 | officers | Termination director company with name termination date | |
| 2026-04-27 | SH01 | capital | Capital allotment shares | |
| 2026-03-27 | TM01 | officers | Termination director company with name termination date | |
| 2025-10-09 | AP01 | officers | Appoint person director company with name date | |
| 2025-10-07 | TM01 | officers | Termination director company with name termination date | |
| 2025-07-23 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-06-09 | AA | accounts | Accounts with accounts type full | |
| 2025-04-24 | AP01 | officers | Appoint person director company with name date | |
| 2025-04-07 | TM01 | officers | Termination director company with name termination date | |
| 2025-01-31 | TM01 | officers | Termination director company with name termination date | |
| 2024-10-11 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-10-02 | SH01 | capital | Capital allotment shares | |
| 2024-09-23 | CH01 | officers | Change person director company with change date | |
| 2024-09-23 | CH01 | officers | Change person director company with change date | |
| 2024-09-23 | CH01 | officers | Change person director company with change date | |
| 2024-09-11 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2024-07-18 | AD02 | address | Change sail address company with old address new address |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 8
- Capital events
- 2
- Officers appointed
- 1
- Officers resigned
- 3
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.